The Munich University Hospital completes new radiopharmaceutical centre in co-operation with University of Erlangen spin-out PET Net.

Munich University Hospital (MUH) has completed construction of a $15m radiopharmaceutical centre which it built in partnership with PET Net, a spin-out from the University of Erlangen.

Focusing on the field of nuclear medicine, the radiopharmaceutical spin-out will work in tandem with MUH on research, teaching, and patient care. It will also be used for the development and production of future radiopharmaceuticals.

Nuclear medicine can be used in not only the treatment of cancer, but also in paediatrics, skeletal diseases,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?